Provided by Tiger Trade Technology Pte. Ltd.

First Trust Nasdaq Pharmaceuticals ETF

41.54
+0.18750.45%
Volume:80.04K
Turnover:3.32M
Market Cap:1.05B
PE:- -
High:41.70
Open:41.70
Low:41.38
Close:41.35
52wk High:42.87
52wk Low:27.30
Shares:25.35M
Float Shares:25.35M
Volume Ratio:0.62
T/O Rate:0.32%
Dividend:0.43
Dividend Rate:1.02%
ROE:--
ROA:--
PB:--
PE(LYR):- -

Loading ...

Perrigo Co. PLC Stock Outperforms Competitors on Strong Trading Day

Dow Jones
·
Aug 29

US FDA - Approves Stelara for Pediatric Ulcerative Colitis

THOMSON REUTERS
·
Aug 29

AbbVie Inc. Stock Underperforms Friday When Compared to Competitors

Dow Jones
·
Aug 29

Eli Lilly (LLY) Wins FDA Approval For Mounjaro Heart Risk Reduction

Simply Wall St.
·
Aug 29

AbbVie Targets Rare Blood Disorder With New Phase 3 Etentamig Trial Plan

TIPRANKS
·
Aug 29

Sector Update: Health Care Stocks Mixed Pre-Bell Friday

MT Newswires Live
·
Aug 28

Lobe Sciences Names David Kideckel CFO as Mirza Rahimani Shifts to VP Finance

Reuters
·
Aug 28

Success After a Century of Failures: Inside Moderna and Merck's Cancer Vaccine Breakthrough

Reuters
·
Aug 28

FDA Approves Lilly's Mounjaro to Cut Cardiovascular Event Risk in High-Risk Type 2 Diabetes Adults

Reuters
·
Aug 28

FDA Approves Lilly's Mounjaro (Tirzepatide) to Reduce Cardiovascular Risk in Adults with Type 2 Diabetes

THOMSON REUTERS
·
Aug 28

Sweden's Elicera Therapeutics Q2 Loss Widens

Reuters
·
Aug 28

Dow Jones Top Company Headlines at 11 PM ET: Judge Rules Trump Administration's Blacklisting of Anthropic was Unlawful | Nvidia ...

Dow Jones
·
Aug 28

Medtronic PLC Stock Underperforms Thursday When Compared to Competitors

Dow Jones
·
Aug 28

Bristol-Myers Squibb Extends Deucravacitinib Program, Signaling Long-Term Autoimmune Ambitions

TIPRANKS
·
Aug 28

Eli Lilly (LLY) Says Zepbound Cuts Healthcare Costs For Adults Over 55

Simply Wall St.
·
Aug 27

China's HBM Holdings H1 Revenue Rises on Progress on Mid-Late Clinical Stage Programs

Reuters
·
Aug 27

China's JW Therapeutics Interim Revenue Rises 4.7% on Carteyva Sales

Reuters
·
Aug 27

China Approves J&J's Oral Psoriasis Pill, Says Drugmaker

Reuters
·
Aug 27

Johnson & Johnson Says Oral Icotrokinra Approved in China for Moderate-to-Severe Plaque Psoriasis - Statement

THOMSON REUTERS
·
Aug 27

AbbVie Seeks EMA Approval for Skyrizi Subcutaneous Induction in Crohn’s Disease

Reuters
·
Aug 27